Evidence map›Paper›PMID 20145078›Full record

ArticleAntimicrobial agents and chemotherapy2010

Cutaneous model of invasive aspergillosis.

Ronen Ben-Ami, Russell E Lewis, Konstantinos Leventakos, Jean-Paul Latgé, Dimitrios P Kontoyiannis

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Bioactive Peptides Against Fungal Biofilms.Frontiers in microbiology · 2019
    Review
  6. Methodologies forMicrobial cell (Graz, Austria) · 2018
    Review
  7. Rodent Models of Invasive Aspergillosis due toFrontiers in microbiology · 2017
    Review
  8. Article
  9. Review
  10. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Iron homeostasis--Achilles' heel of Aspergillus fumigatus?Current opinion in microbiology · 2011
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ronen Ben-AmiDepartment of Infectious Diseases, Infection Control and Employee Health, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.
Russell E Lewis
Konstantinos Leventakos
Jean-Paul Latgé
Dimitrios P Kontoyiannis
The University of Texas MD Anderson Cancer Center · USInstitut Pasteur · FRUniversity of Houston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS CA16672NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Cutaneous models have proven useful in studies of the pathogenesis and treatment of Gram-positive bacterial infections. Because cutaneous invasive aspergillosis (IA) occurs in the clinical setting, we sought to develop a nonlethal murine cutaneous model of IA. We induced cutaneous IA in cyclophosphamide-treated nude BALB/c mice by subcutaneous injection of Aspergillus fumigatus conidia. Skin lesion areas correlated well with tissue fungal burdens, allowing dynamic visual monitoring of cutaneous infections. The cutaneous model accurately reflected alterations in A. fumigatus pathogenicity resulting from deletions of recognized virulence genes (pabaA, sidA, and pksP). Moreover, analysis of the roles of conidial and mycelial catalases revealed that the former is required for the initiation of cutaneous aspergillosis, whereas the latter contributes to its propagation. Finally, posaconazole treatment reduced skin lesion areas relative to those of untreated and fluconazole-treated controls. This novel cutaneous model system should be applicable to comparative studies of the pathogenesis, treatment, and tissue specificity of IA.

Indexed as

Disease Models, AnimalMice, NudeAnimalsAntifungal AgentsAspergillosisAspergillus fumigatusCatalaseCyclophosphamideDermatomycosesFemaleGalactoseHyphaeImmunocompromised HostImmunosuppressive AgentsMannansMiceAntifungal AgentsCatalaseCyclophosphamidegalactomannanGalactoseImmunosuppressive AgentsMannansposaconazoleTriazolesVirulence Factors

Identifiers

PMID20145078
PMCPMC2863682
OpenAlexW2156169647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.